Robeco Institutional Asset Management B.V., a registered investment adviser, initiated a new position in AbbVie Inc. (NYSE:ABBV) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 3,210,141 shares of the Healthcare company, valued at approximately $733.5M as of the filing date.
AbbVie Inc.'s stock currently trades at $219.11 with a market capitalization of $395.7B.